| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8822779 | European Journal of Radiology | 2018 | 8 Pages |
Abstract
The contrast enhancement on CE-CBBCT best discriminates between malignant and benign breast lesions at 2Â min after CM injection. The enhancement has the potential to differentiate histopathological subtypes, with highest enhancement among malignant lesions seen for DCIS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Johannes Uhlig, Uwe Fischer, Alexey Surov, Joachim Lotz, Susanne Wienbeck,